Companies

Chinese pharma firm seeks up to $741m in HK IPO: report

(Agencies)
Updated: 2010-10-11 17:04
Large Medium Small

Sihuan Pharmaceutical Holdings Group seeks to raise up to $741 million through its Hong Kong initial public offering (IPO), according to a term sheet on Oct 11.

Related readings:
Chinese pharma firm seeks up to $741m in HK IPO: report Chinese pharma sales to boost global demand
Chinese pharma firm seeks up to $741m in HK IPO: report Great progress made in rural medical reform: minister
Chinese pharma firm seeks up to $741m in HK IPO: report China needs to upgrade health care facilities: expert

The company has set a price range of HK$3.88-HK$4.60 (50 cents - 59 cents) for its offering, the term sheet said, representing the equivalent of 2011 price to earning multiple of 22.5 times to 26.7 times.

The joint global coordinators are Morgan Stanley and UBS AG, according to the term sheet.